Biogen Inc.

NASDAQ: BIIB
$264.80
-$5.41 (-2.0%)
Closing price October 22, 2021
Thursday's top analyst upgrades and downgrades included Activision Blizzard, Biogen, Carnival, Krispy Kreme, Lam Research, Las Vegas Sands, Tesla and Zoom Video.
Thursday's top analyst upgrades and downgrades included Amgen, Biogen, Commscope, Lockheed Martin, Northrop Grumman, ONEOK, Plug Power and Roku.
Warren Buffett's stock portfolio increased by $26.8 billion in the second quarter. Here's how.
Friday’s top analyst upgrades and downgrades included Biogen, Cirrus Logic, Delta Air Lines, Lennar, Match, Occidental Petroleum, Tupperware and United Airlines.
Monday afternoon's analyst research calls were on Biogen, Ingersoll Rand, Peloton Interactive, Yeti and more.
Friday's top analyst upgrades and downgrades included Biogen, CME, Dropbox, DocuSign, Nvidia, Ping Identity, Signet Jewelers and Tilray.
24/7 Wall St. looks at some big analyst calls that we have seen so far on Thursday, including American Airlines, Biogen, Dow, Medtronic and Zoom Video.
Tuesday's top analyst upgrades and downgrades included Autodesk, Biogen, Delta Air Lines, Facebook, Johnson Controls and Marvell Technology.
These four quality Jefferies stock picks have value characteristics but also appear to have the hidden potential to have momentum stock upside. Note that two are technology names that have been hit...
Sometimes, stocks that are perceived as growth stocks slip into value metrics, and that can lead to some big gains for investors. Four quality stock picks from Jefferies have those characteristics...
The Friday afternoon analyst calls were focused on Biogen, Fortinet, Pinterest, Snap and more.
Earnings season is in full swing, and we have put together a preview of some of the world’s largest players in the health care sector reporting this coming week.
The Friday afternoon analyst calls were focused on Biogen, 3D Systems, Duke Energy, Ford, and more.
Tuesday's midday analyst calls included Peloton Interactive, Biogen, Square and Lockheed Martin.
The November 30 short interest data has been compared with the previous report, and short interest moves in these selected biotech stocks were mixed.